HERON THERAPEUTICS INC's ticker is HRTX and the CUSIP is 427746102. A total of 205 filers reported holding HERON THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.55 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $42,596 | -11.2% | 41,355 | 0.0% | 0.00% | – |
| Q2 2023 | $47,972 | -19.4% | 41,355 | +4.9% | 0.00% | – |
| Q1 2023 | $59,533 | -39.6% | 39,426 | 0.0% | 0.00% | – |
| Q4 2022 | $98,565 | -40.8% | 39,426 | 0.0% | 0.00% | – |
| Q3 2022 | $166,378 | +51.3% | 39,426 | 0.0% | 0.00% | – |
| Q2 2022 | $110,000 | -46.9% | 39,426 | +8.7% | 0.00% | – |
| Q1 2022 | $207,000 | -37.8% | 36,274 | -0.7% | 0.00% | -100.0% |
| Q4 2021 | $333,000 | -87.5% | 36,533 | -85.3% | 0.00% | -80.0% |
| Q3 2021 | $2,655,000 | -34.4% | 248,367 | -4.8% | 0.01% | -37.5% |
| Q2 2021 | $4,049,000 | +11.0% | 260,919 | +16.0% | 0.01% | +14.3% |
| Q1 2021 | $3,647,000 | -34.6% | 224,992 | -14.6% | 0.01% | -36.4% |
| Q4 2020 | $5,577,000 | +930.9% | 263,518 | +622.5% | 0.01% | +1000.0% |
| Q3 2020 | $541,000 | +5.5% | 36,473 | +4.5% | 0.00% | 0.0% |
| Q2 2020 | $513,000 | +3.6% | 34,894 | -17.2% | 0.00% | 0.0% |
| Q1 2020 | $495,000 | -48.7% | 42,129 | +2.6% | 0.00% | -50.0% |
| Q4 2019 | $965,000 | +80.4% | 41,077 | +42.1% | 0.00% | +100.0% |
| Q3 2019 | $535,000 | -0.4% | 28,902 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $537,000 | -22.3% | 28,902 | +2.3% | 0.00% | -50.0% |
| Q1 2019 | $691,000 | -5.7% | 28,255 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $733,000 | -14.2% | 28,255 | +4.8% | 0.00% | 0.0% |
| Q3 2018 | $854,000 | -12.0% | 26,972 | +7.9% | 0.00% | 0.0% |
| Q2 2018 | $971,000 | +59.7% | 24,993 | +13.5% | 0.00% | +100.0% |
| Q1 2018 | $608,000 | +64.8% | 22,011 | +8.0% | 0.00% | 0.0% |
| Q4 2017 | $369,000 | +12.2% | 20,377 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $329,000 | +16.7% | 20,377 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $282,000 | +33.0% | 20,377 | +44.4% | 0.00% | – |
| Q1 2017 | $212,000 | +22.5% | 14,110 | +6.8% | 0.00% | – |
| Q4 2016 | $173,000 | -24.1% | 13,211 | 0.0% | 0.00% | – |
| Q3 2016 | $228,000 | -4.2% | 13,211 | 0.0% | 0.00% | -100.0% |
| Q2 2016 | $238,000 | -5.2% | 13,211 | 0.0% | 0.00% | 0.0% |
| Q1 2016 | $251,000 | -28.9% | 13,211 | 0.0% | 0.00% | 0.0% |
| Q4 2015 | $353,000 | +9.6% | 13,211 | 0.0% | 0.00% | 0.0% |
| Q3 2015 | $322,000 | -21.8% | 13,211 | 0.0% | 0.00% | 0.0% |
| Q2 2015 | $412,000 | +64.1% | 13,211 | -23.4% | 0.00% | 0.0% |
| Q1 2015 | $251,000 | +44.3% | 17,249 | 0.0% | 0.00% | – |
| Q4 2014 | $174,000 | +20.8% | 17,249 | 0.0% | 0.00% | – |
| Q3 2014 | $144,000 | -32.4% | 17,249 | 0.0% | 0.00% | – |
| Q2 2014 | $213,000 | – | 17,249 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG KEVIN C | 760 | $783 | 100.00% |
| Velan Capital Investment Management LP | 6,986,744 | $7,196,346 | 5.80% |
| Tejara Capital Ltd | 2,109,681 | $2,172,971 | 1.23% |
| JW Asset Management, LLC | 2,407,418 | $2,479,641 | 1.07% |
| Rubric Capital Management LP | 26,713,503 | $27,514,908 | 1.03% |
| GREAT POINT PARTNERS LLC | 4,737,368 | $4,879,489 | 0.89% |
| Orchard Capital Management, LLC | 2,142,823 | $2,207,108 | 0.82% |
| Clearline Capital LP | 6,149,842 | $6,334,338 | 0.54% |
| CM Management, LLC | 450,000 | $463,500 | 0.49% |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 327,450 | $337,274 | 0.48% |